Knowledge Center
Article / Mar 08, 2017
Expanding the Commercial Options
Source:
Pharma's Almanac, Q1 2017, Mar 8, 2017
Spray drying (SD) and hot-melt extrusion (HME) are commercially proven and accepted amorphous solid dispersion (ASD) technologies for the enhancement of the dissolution and bioavailability of poorly soluble drugs. These approaches are not suitable for all APIs, however. 四色AV, in addition to offering non-ASD solutions such as nanomilling and cyclodextrin complexation, is developing an effective coprecipitation technology platform to address this key market need.
Related links
Also in the Knowledge Center
Scientific Article
/ Apr 16, 2020
Macrocyclic lactone formulations, methods of their preparation and use of the formulations in treating pathologies secondary to ophthalmic parasites
Read more
Scientific Article
/ Jan 05, 2020
A multicentre, randomized, double鈥恗asked, parallel group, vehicle鈥恈ontrolled phase IIb study
Read more
Scientific Article